Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome.
作者:
主题词
碱基序列(Base Sequence);细胞系(Cell Line);剂量效应关系, 药物(Dose-Response Relationship, Drug);外显子(Exons);核不均一核糖核蛋白F-H组(Heterogeneous-Nuclear Ribonucleoprotein Group F-H);核不均一核糖核蛋白类(Heterogeneous-Nuclear Ribonucleoproteins);人类(Humans);内含子(Introns);萤光素酶类(Luciferases);分子序列数据(Molecular Sequence Data);突变(Mutation);肌无力综合征, 先天性(Myasthenic Syndromes, Congenital);多聚嘧啶区结合蛋白质(Polypyrimidine Tract-Binding Protein);启动区, 遗传(Promoter Regions, Genetic);蛋白质结合(Protein Binding);RNA剪接位点(RNA Splice Sites);RNA剪接(RNA Splicing);受体, 烟碱(Receptors, Nicotinic);序列缺失(Sequence Deletion);单宁类(Tannins)
DOI
10.1093/hmg/ddp023
PMID
19147685
发布时间
2021-10-20
- 浏览8

Human molecular genetics
1229-37页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文